MDT

96.91

-0.67%↓

A

147.87

-0.47%↓

VEEV

232.45

-3%↓

HQY

84.34

-10.55%↓

PHR.US

17.13

-0.23%↓

MDT

96.91

-0.67%↓

A

147.87

-0.47%↓

VEEV

232.45

-3%↓

HQY

84.34

-10.55%↓

PHR.US

17.13

-0.23%↓

MDT

96.91

-0.67%↓

A

147.87

-0.47%↓

VEEV

232.45

-3%↓

HQY

84.34

-10.55%↓

PHR.US

17.13

-0.23%↓

MDT

96.91

-0.67%↓

A

147.87

-0.47%↓

VEEV

232.45

-3%↓

HQY

84.34

-10.55%↓

PHR.US

17.13

-0.23%↓

MDT

96.91

-0.67%↓

A

147.87

-0.47%↓

VEEV

232.45

-3%↓

HQY

84.34

-10.55%↓

PHR.US

17.13

-0.23%↓

Search

Smith & Nephew PLC ADR

Отворен

32.39 -4.26

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

32.48

Максимум

33.86

Ключови измерители

By Trading Economics

Приходи

296M

Продажби

3B

P/E

Средно за сектора

29.768

87.826

Дивидентна доходност

2.29

Марж на печалбата

9.895

Служители

17,000

EBITDA

723M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+4.65% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

2.29%

2.26%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

14B

Предишно отваряне

36.65

Предишно затваряне

32.39

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

Smith & Nephew PLC ADR Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

12.01.2026 г., 23:54 ч. UTC

Пазарно говорене

CBA Could Underperform Again in 2026 -- Market Talk

12.01.2026 г., 23:48 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

12.01.2026 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Rise on Weaker Yen -- Market Talk

12.01.2026 г., 23:43 ч. UTC

Пазарно говорене

Gold Edges Lower on Likely Technical Correction -- Market Talk

12.01.2026 г., 23:18 ч. UTC

Придобивния, сливания и поглъщания

Paramount Sues Warner Bros., Plans Proxy Fight. The Ellisons Aren't Giving Up. -- Barrons.com

12.01.2026 г., 21:56 ч. UTC

Пазарно говорене

Light & Wonder Gets Positive Outcome From Lawsuit -- Market Talk

12.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

12.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

12.01.2026 г., 21:50 ч. UTC

Пазарно говорене
Печалби

Auto & Transport Roundup: Market Talk

12.01.2026 г., 21:18 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

12.01.2026 г., 21:18 ч. UTC

Пазарно говорене

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

12.01.2026 г., 20:54 ч. UTC

Печалби

Gap, Fortinet, and More Stocks That Usually Outperform After Earnings -- Barrons.com

12.01.2026 г., 20:48 ч. UTC

Пазарно говорене

Oil Futures Settle Higher in Choppy Trade -- Market Talk

12.01.2026 г., 20:33 ч. UTC

Пазарно говорене

U.S. Natural Gas Jumps on Colder Weather Outlook -- Market Talk

12.01.2026 г., 20:18 ч. UTC

Придобивния, сливания и поглъщания

Credit Agricole Sees Banco BPM Stake Helping 2025 Net by EUR200M >ACA.FR

12.01.2026 г., 20:18 ч. UTC

Придобивния, сливания и поглъщания

Credit Agricole: European Central Bank Approves Crossing of 20% Threshold in Share Capital of Banco BPM

12.01.2026 г., 19:39 ч. UTC

Пазарно говорене

J&J CEO: Trump Pact Allows Company to Focus on Core Operations -- Market Talk

12.01.2026 г., 19:36 ч. UTC

Пазарно говорене

Gold and Silver Set New Records on Fed Probe -- Market Talk

12.01.2026 г., 19:36 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

12.01.2026 г., 19:33 ч. UTC

Пазарно говорене

Venezuela's 'Proven' Oil Reserves Raises Questions -- Market Talk

12.01.2026 г., 19:24 ч. UTC

Придобивния, сливания и поглъщания

Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23

12.01.2026 г., 19:22 ч. UTC

Придобивния, сливания и поглъщания

Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'

12.01.2026 г., 18:21 ч. UTC

Придобивния, сливания и поглъщания

Paramount Plans Proxy Fight to Push Hostile Warner Bid -- 2nd Update

12.01.2026 г., 18:20 ч. UTC

Придобивния, сливания и поглъщания

This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com

12.01.2026 г., 18:19 ч. UTC

Пазарно говорене

Modest Canadian Economic Impact Seen from Venezuela Changes -- Market Talk

12.01.2026 г., 18:16 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Comcast Could Unlock Value With a Spinoff of NBCUniversal Assets, Analysts Say -- Market Talk

12.01.2026 г., 18:09 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

12.01.2026 г., 18:09 ч. UTC

Пазарно говорене

Baidu's Outlook Bodes Well For Shares -- Market Talk

12.01.2026 г., 18:01 ч. UTC

Придобивния, сливания и поглъщания

QXO Is Raising Another $1.8 Billion for Its M&A War Chest -- Barrons.com

12.01.2026 г., 18:00 ч. UTC

Пазарно говорене

Canada's 'Breakeven' Employment Recalibrating -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Smith & Nephew PLC ADR Прогноза

Ценова цел

By TipRanks

4.65% нагоре

12-месечна прогноза

Среден 35.75 USD  4.65%

Висок 37.5 USD

Нисък 34 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Smith & Nephew PLC ADR през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

2 ratings

0

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

26.64 / 28.37Подкрепа & съпротива

Краткосрочен план

Bullish Evidence

Средносрочен план

Bullish Evidence

Дългосрочен план

Bullish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat